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microbiological	 analyses	 of	 respiratory	 samples	 taken	 from	 pri‐
mary	 care	 patients,	 to	 assist	 in	 the	 interpretation	 of	 syndromic	
data	derived	from	the	same	patient	population.	In	contrast,	popu‐
lation‐based,	participatory	surveillance	systems	typically	lack	this	









cost	 low,	 the	 very	 nature	 of	 these	 participatory	 surveillance	 in‐
struments	calls	for	a	simple	mechanism	of	respiratory	sample	col‐
lection	 by	 participants	 themselves.	 Self‐collection	may	 be	more	
acceptable	 when	 nasal	 or	 particularly	 anterior	 nasal	 swabs	 can	
be	 used.	 While	 in	 clinical	 practice	 pharyngeal	 or	 nasopharyn‐
geal	 swabs	 are	 taken	 frequently	 for	 upper	 respiratory	 illness,	 it	
has	been	shown	that	for	 influenza	and	other	respiratory	viruses,	
nasal	 swabs	are	at	 least	equally	 sensitive	 if	not	 superior	 to	pha‐














participants	 answer	 questions	 on	 demographic	 variables,	 lifetime	




online	 questionnaire.	 In	 this	 questionnaire,	 participants	 are	 asked	













2.2 | Study population and recruitment
For	 the	purpose	of	 this	study,	we	had	bought	multiplex	PCR	tests	
RespiFinder®	 2SMART	 (Pathofinder,	Maastricht,	 NL)	 (see	 section	






















to	be	 enrolled	 in	 the	 study.	Consent	 forms	 for	 children	had	 to	be	




















hold	 received	 a	 kit	 including	 an	 information	 leaflet	 explaining	 the	
procedures,	an	 instruction	on	how	to	 take	an	anterior	nasal	 swab,	
three	swabs	per	adult	and	four	swabs	per	child	with	corresponding	


























paid	packaging	material	 so	 that	 swabs	and	questionnaires	 could	be	
sent	by	mail	to	the	collaborating	laboratory	at	the	RKI.










Following	 the	 purification	 protocol	 of	 viral	 nucleic	 acids	 for	 fluid	
samples,	we	extracted	nucleic	 acids	 from	200	µl	of	 the	 swab	me‐
dium	(Flocked	Swab	with	UTM,	Fa.	COPAN	Flock	Technologies	srl.,	




RNA/DNA	were	 stored	 at	 −80°C	before	 and	 after	 the	 analysis.	A	
pooled	medium	sample	from	three	humans	who	had	tested	negative	
previously	was	used	as	a	negative	extraction	control.
Self‐collected	 swabs	 were	 analysed	 for	 22	 viral	 and	 bacte‐
rial	 pathogens	 using	 the	 RespiFinder®	 2SMART	 (Pathofinder,	
Maastricht,	 NL)	 according	 to	 the	 manufacturer's	 protocol.	 Tested	
pathogens	 included	 influenza	 A,	 influenza	 A(H1N1)pdm09,	 influ‐
enza	 B,	 parainfluenza‐1,	 parainfluenza‐2,	 parainfluenza‐3,	 parain‐
fluenza‐4,	 RSV‐A,	 RSV‐B,	 human	 metapneumovirus,	 rhinovirus/
enterovirus,	bocavirus	(type	1),	adenovirus,	coronavirus	NL63,	coro‐
navirus	 HKU1,	 coronavirus	 229E,	 coronavirus	 OC43,	Mycoplasma 




Because	 the	 laboratory	 analysis	 included	 notifiable	 diseases	
(according	 to	 the	 “Protection	 against	 Infection	 Act”	 (www.ge‐
setze‐im‐internet.de/ifsg/),	 namely	 influenza, whooping	 cough	










analysed	 them	 with	 Stata	 version	 14	 (Stata	 Corporation,	 College	




To	 evaluate	 completeness	 of	 swabbing,	 we	 compared	 results	
from	the	group	of	randomly	selected	participants	with	that	among	
participating	staff	members	of	the	RKI.	To	do	this,	we	first	merged	
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the	GrippeWeb	and	GrippeWeb‐Plus	databases	and	then	compared	
(a)	the	proportion	of	swabs	where	a	respiratory	illness	was	reported	
and	 (b)	 the	 proportion	 of	 respiratory	 illnesses	 that	were	 reported	
online	where	a	swab	was	taken.	Proportions	were	analysed	using	the	








completeness	of	 swabbing	 (see	above);	 (d)	 the	proportion	of	eval‐
uation	 forms	 returned;	 and	 (e)	 if	 samples	 contained	 the	 human	 c‐
myc‐gene	which	can	only	be	found	in	human	cells.	To	test	external	
validity,	we	compared	virological	results	with	that	of	the	virological	
surveillance	 system	 of	 the	 physician	 sentinel	 AGI.12	 Because	 AGI	
physicians	take	swabs	from	patients	with	ILI,	we	compared	positivity	
rates	 (PRs)	 of	 influenza	 and	 rhinoviruses	 also	 among	GrippeWeb‐
Plus	participants	presenting	with	 ILI.	Of	note,	 the	 ILI	 definition	 in	
the	AGI	 includes	 fever	+	one	systemic	 symptom	such	as	headache	
or	 myalgia	+	one	 respiratory	 symptom	 and	 differs	 therefore	 from	





culated.	 For	 the	 period	of	 influenza	 circulation	 (PIC),	we	used	 the	
definition	provided	by	the	AGI	(week	2‐week	15	[2016]).




2.7 | Data protection and ethics approval
GrippeWeb‐Plus	 was	 carried	 out	 according	 to	 the	 German	 leg‐
islation	 on	 data	 protection.	 The	 GrippeWeb‐Plus	 procedures	
were	 approved	 by	 the	 German	 Federal	 Commissioner	 for	 Data	
Protection	 and	 Freedom	 of	 Information	 (ID:	 III‐401/008#0072).	
The	GrippeWeb‐Plus	study	was	approved	by	the	Ethics	Committee	
of	the	Charité,	Ethikausschuss	2	am	Campus	Virchow‐Klinikum	(ID:	










Furthermore,	 the	 11	RKI	 employees	 signed	 up	 six	 (100%)	 of	 their	
children.	In	total,	this	led	to	73	adults	and	30	children	participating	in	
the	GrippeWeb‐Plus	study	(Figure	1).

















children (n = 24 )
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ticipants,	 58	 swabs	were	 from	 asymptomatic	 participants,	 and	 16	











The	 proportion	 of	 swabs	 of	 participants	with	 symptoms	 (n	=	151)	
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indicated	 that	 self‐swabbing	 was	 either	 unproblematic	 or	 briefly	


















ent	 pathogens	 and	 in	 one	 swab	 (0.8%)	 three	 different	 pathogens,	






cornaviruses	 (rhino‐/enteroviruses)	 dominated	with	 42%,	 followed	
by	coronaviruses	with	23%,	orthomyxoviruses	 (influenza	A	and	in‐
fluenza	B)	with	12%	and	bocaviruses	with	10%.







PR	was	 independent	of	 the	 amount	of	 c‐myc‐DNA	 identified.	The	
PR	 by	 interval	 from	 symptom	 onset	 until	 day	 of	 swabbing	 varied	
Pathogen
All swabs Symptomatic Asymptomatic Unknown
n % n % n % n %
Rhino‐/enterovirus 60 42 54 42 4 40 2 40
CoV	NL63/HKU1 25 17 20 16 3 30 2 40
Bocavirus 15 10 12 9.4 2 20 1 20
INV	A(H1N1)pdm09 10 7.0 10 7.8 0 0 0 0
INV	B 7 4.9 7 5.5 0 0 0 0
CoV	229E 5 3.5 5 3.9 0 0 0 0
RSV	A 5 3.5 5 3.9 0 0 0 0
hMPV 5 3.5 5 3.9 0 0 0 0
CoV	OC43 3 2.1 3 2.3 0 0 0 0
Adenovirus 2 1.4 1 0.8 1 10 0 0
RSV	B 2 1.4 2 1.6 0 0 0 0
PIV1 2 1.4 2 1.6 0 0 0 0
PIV	2 1 0.7 1 0.8 0 0 0 0
PIV	3 1 0.7 1 0.8 0 0 0 0
PIV4 0 0 0 0 0 0 0 0
INV	A(H3N2) 0 0 0 0 0 0 0 0
Mycoplasma 
pneumoniae
0 0 0 0 0 0 0 0
Legionella 
pneumophila
0 0 0 0 0 0 0 0
Bordetella pertussis 0 0 0 0 0 0 0 0
Chlamydophila 
pneumoniae
0 0 0 0 0 0 0 0
Total 143 100 128 100 10 100 5 100
CoV	=	coronavirus;	 hMPV	=	human	metapneumovirus;	 INV	=	influenza;	 PIV	=	parainfluenza	 virus;	
RSV	=	respiratory	syncytial	virus.
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between	55%	and	81%	when	 the	 swab	was	 taken	between	0	and	
6	days	 (Figure	2).	Between	1	day	and	4	days,	 it	was	between	71%	





3.7.1 | PR for influenza and rhino‐/enterovirus 







3.7.2 | PR for influenza and rhino‐/enterovirus 
among participants with ILI and comparison with ILI 













higher	 by	 proximately	 20	 percentage	 points	 (Figure	 3,	 lower	 right	
panel).
3.7.3 | PR for influenza vs non‐influenza viruses by 
syndrome and during/after PIC
During	 the	PIC,	 influenza	A	and	 influenza	B	were	detected	 in	one	
swab	(1.7%)	and	two	swabs	(3.4%;	in	total	5.1%),	respectively,	among	











Among	swabs	 from	asymptomatic	participants,	 samples	 from	chil‐
dren	were	as	likely	to	yield	a	pathogen	as	those	from	adults	(children:	








detected	 and	 47	 of	 143	 pathogen	 detections	 (33%)	 occurred	
TA B L E  3  Positivity	rates	of	swabs	by	presence	of	symptoms	among	participants,	Germany,	January‐July	2016
Swabs (n = 225) among…
Swab positivity Number of pathogens detected
Negative Positive (%) 1 (%) 2 (%) 3 (%)
Participants	with	symptoms	(n	=	151) 44 107	(71) 87	(81) 19	(18) 1	(1)
Participants	without	symptoms	(n	=	58) 50 8	(14) 6	(75) 2	(25) 0	(0)
Participants	with	no	information	about	symptoms	(n	=	16) 12 4	(25) 3	(75) 1	(25) 0	(0)
F I G U R E  2  Positivity	rate	by	interval	between	symptom	onset	
and	day	of	swabbing;	data	point	for	6	d	is	pooled	from	days	5	to	7,	
January‐July	2016,	Germany
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within	 a	 co‐infection	 of	 two	 (22	 times)	 or	 three	 viruses	 (once).	
Double	 or	 triple	 infections	 among	 0‐4‐year‐old	 children	 repre‐
sented	 44%	 (12/27),	 among	 5‐14‐year‐old	 children	 17%	 (5/30)	
and	among	adults	10%	(6/62)	of	positive	samples	(P‐value	0.003).	
Stratified	 by	 pathogen,	 the	 proportion	 of	 detections	 as	 double	
or	 triple	 infection	 varied	 widely	 among	 pathogens	 and	 ranged	
from	0%	(CoV	229E,	RSV‐B,	PIV2)	to	100%	(PIV3;	n	=	1;	Table	4).	
Bocaviruses	were	detected	in	73%	within	a	double	or	triple	infec‐
tion.	 Of	 the	 pathogen,	most	 often	 detected	 (rhino‐/enterovirus)	
in	 18%	 the	 patient	was	 co‐infected	with	 another	 pathogen.	 The	
co‐infection	matrix	 in	Table	5	 shows	how	often	which	 combina‐











was	 substantial;	 (b)	 swabs	were	 taken	 timely	 and	were	 almost	 al‐
ways	accompanied	by	an	online	report	via	the	GrippeWeb	system;	
(c)	 self‐swabbing	was	mostly	 perceived	 as	 unproblematic	 and	was	
well	accepted,	among	children	and	adults	alike,	no	injury	occurred;	
(d)	 almost	 all	 participants	would	be	willing	 to	participate	 in	 a	 self‐
swabbing	scheme	for	a	prolonged	period	of	time;	(e)	the	quality	of	
swabs	taken	was	good	as	they	always	contained	DNA	from	human	
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procedures	 should	 build	 on	 the	 positive	 experience	 with	 the	
method	used	in	this	feasibility	study.
Work‐up	 of	 quality	 indicators	 of	 the	 swabs	 submitted	 revealed	
that	 all	 swabs	 contained	 the	 c‐myc‐gene	which	 indicates	 that	 they	
were	taken	with	enough	thoroughness	to	contain	cells	from	the	an‐
terior	nose.	Moreover,	up	to	94%	of	the	swabs	had	a	corresponding	





F I G U R E  5  Pathogen	distribution	among	symptomatic	children	
(≤14	y)	and	adults	(>14	y),	January‐July	2016,	Germany










Rhino/Entero 60 11 18
CoV	NL63/HKU1 25 10 40
Boca 15 11 73
INV	A(H1N1)pdm09 10 4 40
INV	B 7 1 14
RSV	A 5 3 60
hMPV 5 3 60
CoV	229E 5 0 0
CoV	OC43 3 1 33
Adeno 2 1 50
PIV1 2 1 50
RSV	B 2 0 0
PIV	3 1 1 100
PIV	2 1 0 0
PIV4 0 NA NA
INV	A(H3N2) 0 NA NA
     |  11HAUSSIG et Al.





a	 swab	was	 taken	 or	 not	 taken,	 taking	 a	 swab	was	 not	 associated	
with	 symptom	 severity,	 so	 the	 simplest	 explanation	 would	 be	 just	
oversight;	nevertheless,	more	detailed	 information	would	be	useful	
in	the	interpretation	of	results.	Finally,	swabs	were	taken	timely,	and	
the	mean	and	median	delay	 from	symptom	onset	 to	 swabbing	was	

















During	 this	 study,	 a	 large	 variety	 of	 viruses	 was	 detected.	
More	than	70%	of	swabs	from	symptomatic	participants	yielded	at	
least	one	pathogen,	more	than	in	studies	with	a	similar	diagnostic	
spectrum	 (36%11;	 48%16).	 The	 viruses	most	 frequently	 identified	
were	 rhino‐/enterovirus,	 coronaviruses,	 influenza	 viruses	 as	 well	
as	bocavirus.	Except	 for	bocavirus	which	was	not	 tested	 in	other	










Roughly,	 one	 in	 five	 positive	 swabs	 contained	more	 than	 one	

































































































































































































































































































































































































reference	 group	 from	 our	 own	 institute.	 Participants	 were	 very	
willing	 to	participate	 in	 a	 longer	 lasting	 swabbing	 scheme	which	
could	form	the	base	for	continued	surveillance	with	the	goal	to	un‐
derstand	better	the	pathogens	leading	to	ARI	on	population	level.	
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